Sickle cell disease is a common genetic blood disorder. It causes severe systemic complications including ocular involvement. The degree of ocular complications is not necessarily based on the severity of the systemic disease. Both the anterior and posterior segments in the eye can be compromised due to pathological processes of sickle cell disease. However, ocular manifestations in the retina are considered the most important in terms of frequency and visual impairment. Eye complications could be one of the silent systemic sickle cell disease complications. Hence, periodic ophthalmic examination should be added to the prophylactic and treatment protocols. This review article is to emphasize the ocular manifestations in sickle cell disease as it is a silent complication which became neglected issue. Once the ocular complications diagnosed, then treatment to be provided in the specialized ophthalmology centers.
References
[1]
Fadugbagbe, A.O., Gurgel, R.Q., Mendonça, C.Q., et al. (2010) Ocular Manifestations of Sickle Cell Disease. Annals of Tropical Paediatrics, 30, 19-26. https://doi.org/10.1179/146532810X12637745451870
[2]
Tan, A.C.S., Tan, G.S., Denniston, A.K., et al. (2018) An Overview of the Clinical Applications of Optical Coherence Tomography Angiography. Eye (London), 32, 262-286. https://doi.org/10.1038/eye.2017.181
[3]
Cury, D., Boa-Sorte, N., Lyra, I.M., Zanette, A.D., Castro-Lima, H., Galvão-Castro, B. and Gonçalves, M.S. (2010) Ocular Lesions in Sickle Cell Disease Patients from Bahia, Brazil. Revista Brasileira de Oftalmologia, 69, 259-263. https://doi.org/10.1590/S0034-72802010000400010
[4]
Ballas, S.K., Lieff, S., Benjamin, L.J., et al. (2010) Definitions of the Phenotypic Manifestations of Sickle Cell Disease. American Journal of Hematology, 85, 6-13.
[5]
In Mannis, M. J. and In Holland, E.J. (2017) Cornea.
[6]
De Melo, M.B. (2014) An Eye on Sickle Cell Retinopathy. The Revista Brasileira de Hematologia e Hemoterapia, 36, 319-321. https://doi.org/10.1016/j.bjhh.2014.07.020
[7]
Lee, M.K., Han, K.D., Lee, J.H., et al. (2018) High Hemoglobin Levels Are Associated with Decreased Risk of Diabetic Retinopathy in Korean Type 2 Diabetes. Scientific Reports, 8, Article No. 5538. https://doi.org/10.1038/s41598-018-23905-2
[8]
Shukla, P., Verma, H., Patel, S., Patra, P.K. and Bhaskar, L.V.K.S. (2017) Ocular Manifestations of Sickle Cell Disease and Genetic Susceptibility for Refractive Errors. Taiwan Journal of Ophthalmology, 7, 89-93. https://doi.org/10.4103/tjo.tjo_3_17
[9]
Al-Jafar, H.A., Alroughani, R., Abdullah, T.A. and Al-Qallaf, F. (2016) Neurological Complications in Sickle Cell Disease. International Journal of Clinical and Experimental Neurology, 4, 9-18.
[10]
Adewoye, A.H., Ramsey, J., McMahon, L., Sakai, O. and Steinberg, M.H. (2006) Lacrimal Gland Enlargement in Sickle Cell Disease. American Journal of Hematology, 81, 888-889. https://doi.org/10.1002/ajh.20658
[11]
Saito, N., Nadgir, R.N., Flower, E.N. and Sakai, O. (2010) Clinical and Radiologic Manifestations of Sickle Cell Disease in the Head and Neck. RadioGraphics, 30, 1021-1035. https://doi.org/10.1148/rg.304095171
[12]
Bingöl Kızıltunç, P., çiftçi, F., Hoşal, B. and Kaygusuz, G. (2017) Bilaterally Diffuse Lacrimal Gland Involvement: Initial Presentation of Systemic Sarcoidosis. Turkish Journal of Ophthalmology, 47, 165-168. https://doi.org/10.4274/tjo.89310
[13]
Green, M.D.A. (2003) Sickle Cell Disease a Behavioral Approach to a Systemic Disease. Journal of Behavioral Optometry, 14, 3.
[14]
Friberg, T.R., Young, C.M. and Milner, P.F. (1986) Incidence of Ocular Abnormalities in Patients with Sickle Hemoglobinopathies. Annals of Ophthalmology, 18, 150-153.
[15]
Siqueira, W.C., Figueiredo, M.S., Cruz, A.A., Costa, F.F. and Zago, M.A. (1990) Conjunctival Vessel Abnormalities in Sickle Cell Diseases: The Influence of Age and Genotype. Acta Ophthalmologica (Copenh), 68, 515-518. https://doi.org/10.1111/j.1755-3768.1990.tb04779.x
[16]
Cheung, A.T., Miller, J.W., Craig, S.M., To, P.L., Lin, X., Samarron, S.L., Chen, P.C., Zwerdling, T., Wun, T., Li, C.S. and Green, R. (2010) Comparison of Real-Time Microvascular Abnormalities in Pediatric and Adult Sickle Cell Anemia Patients. American Journal of Hematology, 85, 899-901. https://doi.org/10.1002/ajh.21853
[17]
Levin, A.V. and Enzenauer, R.W. (2017) The Eye in Pediatric Systemic Disease. Springer International Publishing, Berlin. https://doi.org/10.1007/978-3-319-18389-3
[18]
Pusoil, A., Pignatto, S., Cadel, I. and Passone, E. (2014) Corneal Leucomas in a Child with Sickle Cell Disease. Journal of Hematology and Thromboembolic Diseases, 2, 4.
[19]
Troup, C. (2019) Leukoma: Causes, Complications, Diagnosis and Treatment: Investigative Study. https://www.tools4noobs.com/summarize
[20]
Li, X.H., Liu, X.H., Yuan, M., et al. (2016) The Histopathological Spectrum of 3592 Corneal Specimen in China. Austin Pathology, 1, 1004.
[21]
Coşkun, M., İlhan, ö., İlhan, N., Tuzcu, E.A., Daglioğlu, M.C., Kahraman, H., Elbeyli, A., Yarbağ, A. and Helvaci, M.R. (2015) Changes in the Cornea Related to Sickle Cell Disease: A Pilot Investigation. European Journal of Ophthalmology, 25, 463-467. https://doi.org/10.5301/ejo.5000598
[22]
Vilensky, J., Robertson, W. and Suarez-Quian, C. (2015) The Clinical Anatomy of the Cranial Nerves: The Nerves of “On Olympus Towering Top”. Wiley-Blackwell, Ames. https://doi.org/10.1002/9781118491959
[23]
George, I.O. and Cookey, S.A.H. (2012) Eye Manifestations of Children with Homozygous Sickle Cell Disease in Nigeria. Journal of Medicine and Medical Sciences, 3, 302-305. http://www.interesjournals.org/JMMS
[24]
Sadun, A.A. and Wang, M.Y. (2011) Chapter 5 Abnormalities of the Optic Disc. In: Kennard, C. and Leigh, R.J., Eds., Handbook of Clinical Neurology, Volume 102, Elsevier, Amsterdam, 117-157. https://doi.org/10.1016/B978-0-444-52903-9.00011-X
[25]
Nasrullah, A. and Kerr, N. (1997) Sickle Cell Trait as a Risk Factor for Secondary Hemorrhage in Children with Traumatic Hyphema. American Journal of Ophthalmology, 123, 783-790. https://doi.org/10.1016/S0002-9394(14)71127-4
[26]
Malik, U. (2020) IrisVision Global. https://irisvision.com/optic-nerve-damage-diseases-and-eye-conditions
[27]
Pandey, N. (2015) Unusual Presentation of Ocular Trauma in Sickle Cell Trait. Indian J Ophthalmol, 63, 738-740. http://doi.org/10.4103/0301-4738.170985
[28]
Goldberg, M.F. (1971) Classification and Pathogenesis of Proliferative Sickle Cell Retinopathy. Am J Ophthalmol, 71, 649-665. https://doi.org/10.1016/0002-9394(71)90429-6
[29]
Eruchalu, U.V., Pam, V.A. and Akuse, R.M. (2004) Sight Threatening Retinopathy in a Child with Sickle Cell β Thalassaemia: Case Report. Annals of African Medicine, 3, 141-143.
[30]
Gliem, M., Zaeytijd, J.D., Finger, R.P., Holz, F.G., Leroy, B.P. and Charbel Issa, P. (2013) An Update on the Ocular Phenotype in Patients with Pseudoxanthoma Elasticum. Frontiers in Genetics, 4, 14. https://doi.org/10.3389/fgene.2013.00014
Oluleye, T.S. (2012) The Pattern of Presentation of Sickle Cell Retinopathy in Ibadan. Journal of Clinical and Experimental Ophthalmology, 3, Article No. 10000257.
[33]
Bonanomi, M.T.B.C. and Lavezzo, M.M. (2013) Sickle Cell Retinopathy: Diagnosis and Treatment. Arquivos Brasileiros de Oftalmologia, 76, 320-327. https://doi.org/10.1590/S0004-27492013000500016
[34]
Gualandro, S.F., Fonseca, G.H., Yokomizo, I.K., Gualandro, D.M. and Suganuma, L.M. (2015) Cohort Study of Adult Patients with Haemoglobin SC Disease: Clinical Characteristics and Predictors of Mortality. British Journal of Haematology, 171, 631-637. https://doi.org/10.1111/bjh.13625
[35]
Elagouz, M., Jyothi, S., Gupta, B. and Sivaprasad, S. (2010) Sickle Cell Disease and the Eye: Old and New Concepts. Survey of Ophthalmology, 55, 359-377. https://doi.org/10.1016/j.survophthal.2009.11.004
[36]
Menaa, F., Khan, B.A., Uzair, B. and Menaa, A. (2017) Sickle Cell Retinopathy: Improving Care with a Multidisciplinary Approach. Journal of Multidisciplinary Healthcare, 10, 335-346. https://doi.org/10.2147/JMDH.S90630
[37]
Butler, F.K., Hagan, C. and Murphy-Lavoie, H. (2008) Hyperbaric Oxygen Therapy and the Eye. Undersea & Hyperbaric Medicine, 35, 333-387.
[38]
Jalali, S. (2003) Retinal Detachment. Community Eye Health, 16, 25-26.
[39]
Brinton, D.A. and Wilkinson, C.P. (2009) Retinal Detachment: Principles and Practice. Third Edition, Oxford University Press Inc., Oxford.
[40]
Farber, M.D., Jampol, L.M., Fox, P., et al. (1991) A Randomised Clinical Trial of Scatter Photocoagulation of Proliferative Sickle Retinopathy. Archives of Ophthalmology, 109, 363-367. https://doi.org/10.1001/archopht.1991.01080030065040
[41]
O’Toole, L. (2010) Management & Investigation of Vascular Conditions. Module 13 Part 6: Clinical Optometry Course Code: C-13921 O/D.
[42]
Obikili, A.G., Oji, E.O. and Onwukeme, K.E. (1990) OCI,Jlarfindings in Homozygous Sickle Cell Disease in Jos, Nigeria. Afr J Med Moo Sci, 19, 245-250.
[43]
Witkin, A.J., Rogers, A.H., Ko, T.H., Fujimoto, J.G., Schuman, J.S. and Duker, J.S. (2006) Optical Coherence Tomography Demonstration of Macular Infarction in Sickle Cell Retinopathy. Archives of Ophthalmology, 124, 746-747. https://doi.org/10.1001/archopht.124.5.746
[44]
Kim, J.Y., Lee, J.H. and Yoon, I. (2010) Macular Infarction Associated with Reactive Arthritis. Korean Journal of Ophthalmology, 24, 310-313. https://doi.org/10.3341/kjo.2010.24.5.310
[45]
Merritt, J.C., Risco, J.M. and Pantell, J.P. (1982) Bilateral Macular Infaction in SS Disease. J PediatrOphthalmol Strabismus, 19, 275-278.
[46]
Mathew, R., Bafiq, R., Ramu, J., Pearce, E., Richardson, M., Drasar, E., Thein, S.L. and Sivaprasad, S. (2015) Spectral Domain Optical Coherence Tomography in Patients with Sickle Cell Disease. British Journal of Ophthalmology, 99, 967-972. https://doi.org/10.1136/bjophthalmol-2014-305532
Dell’Arti, L., Barteselli, G., Riva, L., et al. (2018) Sickle Cell Maculopathy: Identification of Systemic Risk Factors, and Microstructural Analysis of Individual Retinal Layers of the Macula. PLoS ONE, 13, e0193582. https://doi.org/10.1371/journal.pone.0193582
[49]
Ido, M., Osawa, S., Fukukita, M., Sugimoto, M., Wakitani, Y., Ito, Y., Miyamura, M., Sasoh, M. and Uji, Y. (2007) The Use of Colour Doppler Imaging in the Diagnosis of Retinal Detachment. Eye, 21, 1375-1378. https://doi.org/10.1038/sj.eye.6702442
[50]
Kuzmić, A.C., Brkljacić, B., Ivanković, D. and Galesić, K. (2000) Doppler Sonographic Renal Resistance Index in Healthy Children. European Radiology, 10, 1644-1648. https://doi.org/10.1007/s003300000466
[51]
Ferrão, T.O., Martins-Filho, P.R., Aragão, C., et al. (2017) Doppler Velocimetry of the Orbital Arteries in Patients with Sickle Cell Anemia: Relationship with Biomarkers of Hemolysis. Radiologia Brasileira, 50, 103-108. https://doi.org/10.1590/0100-3984.2015.0180
[52]
Quinn, C.T. (2013) Sickle Cell Disease in Childhood: From Newborn Screening through Transition to Adult Medical Care. Pediatr Clin North Am, 60, 1363-1381. https://doi.org/10.1016/j.pcl.2013.09.006
[53]
Yawn, B.P. and John-Sowah, J. (2015) Management of Sickle Cell Disease: Recommendations from the 2014 Expert Panel Report. Am Fam Physician, 92, 1069-1076.
[54]
Riley, T.R., Boss, A., McClain, D. and Riley, T.T. (2018) Review of Medication Therapy for the Prevention of Sickle Cell Crisis. P&T, 43, 417-437.
[55]
Green, D. (2018) L-Glutamine for Sickle Cell Anemia. Reviewing Quinn CT. Blood.
[56]
Carden, M.A. and Little, J. (2019) Emerging Disease-Modifying Therapies for Sickle Cell Disease. Hematologica, 104, 1710-1719. https://doi.org/10.3324/haematol.2018.207357
